# Evidence Ledger — PharmacyOS
Classification: Internal — Client Confidential
Product: PharmacyOS — Winchester Global Pharmacy Operations Platform
Created: 2026-05-07
Protocol: mandatory-build-activation-protocol-2026-04-26.md

---

## Purpose

This ledger records every piece of verification evidence produced during the PharmacyOS build. No artifact advances to Gate 5 without its corresponding evidence entry logged here.

---

## Evidence Log

| Date | Gate | Evidence Type | Result | Produced by | Notes |
|---|---|---|---|---|---|
| 2026-05-07 | Gate 0 | Build Activation Packet | Created | PMA / Codex | Initial packet — awaiting SAA architecture decision |
| 2026-05-07 | Gate 0A | Agent Assessment & Routing | Documented in BAP | MOA / PMA | 6 capability gaps identified — must close before Gate 2 clears |
| — | Gate 1A | SAA Architecture Record | PENDING | SAA (Samara) | Stack, infra, monorepo decision required |
| — | Gate 1A | DSS Schema Approval | PENDING | DSS | 15+ tables; RLS; migrations |
| — | Gate 2 | SCA Auth + JDPA Review | PENDING | SCA (Omari) | Required before any patient data schema finalized |
| — | Gate 2 | legal-compliance skill run | PENDING | LCA (Dorothy) | JDPA consent flow + Jamaica Data Protection Act 2020 |
| — | Gate 4 | TypeScript check | PENDING | TVA (Leandra) | 0 errors required |
| — | Gate 4 | Production build | PENDING | TVA (Leandra) | Must pass |
| — | Gate 4 | Test suite | PENDING | TVA (Leandra) | Coverage target TBD at SAA stage |
| — | Gate 4 | WCAG 2.1 AA audit | PENDING | AAA (Rochelle) | All 43 screens; automated + manual |
| — | Gate 4 | SCA security review | PENDING | SCA (Omari) | Auth, RLS, PII, Lynk, AI upload |
| — | Gate 4 | Claude Vision integration test | PENDING | IDS / TVA | Extraction accuracy, confidence scoring, error handling |
| — | Gate 4 | Lynk payment integration test | PENDING | IDS / TVA | Awaiting client API credentials |
| — | Gate 4 | Schedule drug log format approval | PENDING | Client pharmacist | Required before logging UI is built |
| — | Gate 5 | QAS independent review | PENDING | QAS (Imani) | Scope, evidence, drift check |
| — | Gate 6 | ARE technical review | PENDING | ARE | Required before production deployment |
| — | Gate 6 | Founder authorization | PENDING | Founder | Required before any client access or production deployment |

---

## Prototype Reference Record

| Item | Status | Location |
|---|---|---|
| PharmacyOS Prototype.html | Reference only — not production | prototype/ |
| app.jsx | Reference only — hash-router vanilla React | prototype/ |
| screens-1.jsx | Reference only | prototype/ |
| screens-2.jsx | Reference only | prototype/ |
| screens-3.jsx | Reference only | prototype/ |
| shell.jsx | Reference only | prototype/ |
| icons.jsx | Reference only | prototype/ |
| styles.css | Reference only — design token source | prototype/ |
| Design handoff (Claude Design) | Canonical specification for production build | 00_governance/ |

Prototype is for design validation and stakeholder review only. Production implementation in `app/` follows the design handoff spec, not the prototype code structure.

---

## Open Capability Gaps (Gate 0A)

| # | Gap | Owner | Status |
|---|---|---|---|
| G1 | SAA architecture decision | SAA (Samara) | OPEN |
| G2 | Supabase project not provisioned | PIS + Founder | OPEN — cost authorization required |
| G3 | Claude Vision API access not confirmed | Founder / Codex | OPEN |
| G4 | Lynk payment API credentials absent | Client | OPEN |
| G5 | JDPA compliance review not started | SCA + LCA | OPEN |
| G6 | Schedule drug log format not pharmacist-approved | Client pharmacist | OPEN |
